Teva Pharmaceutical Industries received FDA approval on Thursday for Nifedipine Extended Release Tablets, extending its reach within the cardiovascula...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
SpecGx LLC announced the FDA approval of the Fentanyl Transdermal ANDA (App # ANDA077154) on February 9th, potentially expanding generic competition f...
Senores Pharma has secured FDA approval for its Abbreviated New Drug Application (ANDA090404), a pivotal development expected to bolster the company's...
Zydus Pharmaceuticals USA Inc. received final FDA approval today for the age-restricted immediate-release tablets of glipizide and metformin hydrochlo...
# FDA Approves GE Healthcare's DaTscan for Parkinson's Disease Diagnosis GE Healthcare's Medi-Physics division received FDA approval for DaTscan (iof...
# FDA Approves Alembic Pharmaceuticals' Generic Lamotrigine Alembic Pharmaceuticals Limited has received FDA approval for its generic lamotrigine ora...
January 12 – Glenmark Pharmaceuticals Inc. announced the approval of its generic Atovaquone and Proguanil Hydrochloride for pediatric use, defending i...
# FDA Approval Newswire Rising Pharmaceuticals received FDA approval for a new generic drug formulation (ANDA090431) on December 28, 2010, positionin...
# FDA Approves Amneal Pharmaceuticals' Generic Oxymorphone Hydrochloride Amneal Pharmaceuticals of New York LLC received FDA approval for its generic...
HERITAGE PHARMA AVET announced a new ANDA submission on November 30, signaling the company's continued participation in the pharmaceutical sector thou...
Micro Labs Limited has obtained regulatory approval for Mefenamic Acid oral tablets, opening a new avenue for the Indian generics maker to address inf...
On November 1, 2010, Ascend Laboratories, LLC received FDA approval to market metformin hydrochloride oral tablets, paving the way for increased gener...
GENUS LIFESCIENCES received U.S. approval on Oct. 20 for NDA200534, a drug application; this regulatory milestone positions the company to potentially...
Genus Lifesciences Inc. received FDA approval on October 20, 2010, for OxyCODONE HYDROCHLORIDE (NDA200535), a move expected to bolster the generic mar...
Chartwell RX has announced the approval of its 505(b)(2) application, ANDA090241, placing the company in a favorable position to capitalize on establi...
# FDA Approves Strides Pharma's Generic Losartan Potassium Tablet Strides Pharma Science Limited received FDA approval for its generic losartan potas...
# FDA Approves Lupin Pharmaceuticals' Generic Losartan Potassium Lupin Pharmaceuticals, Inc. received FDA approval for its generic losartan potassium...
On October 6, 2010, Watson Labs received final approval from the FDA for its Abbreviated New Drug Application (ANDA) No. 091129, a move that immediate...
Hikma Pharmaceuticals USA Inc. secured FDA approval to manufacture the generic form of Oxymorphone Hydrochloride, an oral analgesic, providing a cost-...
Areva Pharmaceuticals today announced the approval of its Abbreviated New Drug Application (ANDA090724) for fludarabine phosphate injection, a key off...